Skip to content

ATOSSA THERAPEUTICS, INC.: 10-K filed 2013-03-28

What ATOSSA THERAPEUTICS, INC. reported in its annual report filed 2013-03-28 (fiscal FY 2012): 33 published measures, 92 facts as tagged in accession 0001144204-13-018024.

This filing

Form
10-K (annual report)
Filed
2013-03-28
Fiscal period
fiscal FY 2012
Accession
0001144204-13-018024 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-316,826,133USD
At 2011-12-313,071,894USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-315,175,535USD
At 2011-12-311,559,721USD
At 2010-12-31-851,851USD
At 2009-12-3131,683USD
At 2009-04-3054,000USD
At 2009-04-2954,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-311,725,197USD
At 2011-12-311,910,821USD
At 2010-12-3110,253USD
At 2009-04-300USD
At 2009-04-290USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-5,079,851USD366
2009-05-01 to 2012-12-31-9,731,906USD1341
2011-01-01 to 2011-12-31-3,442,269USD365
2010-01-01 to 2010-12-31-1,086,930USD365
2009-05-01 to 2009-12-31-122,857USD245

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-3,899,964USD366
2009-05-01 to 2012-12-31-7,825,615USD1341
2011-01-01 to 2011-12-31-3,492,364USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,848,922USD366
2009-05-01 to 2012-12-319,822,325USD1341
2011-01-01 to 2011-12-315,529,863USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-134,582USD366
2009-05-01 to 2012-12-31-271,513USD1341
2011-01-01 to 2011-12-31-136,931USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-9,731,906USD
At 2011-12-31-4,652,056USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2009-05-01 to 2012-12-31250USD1341
2011-01-01 to 2011-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31159,967USD
At 2011-12-3180,467USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31121,812USD366
2009-05-01 to 2012-12-31292,264USD1341
2011-01-01 to 2011-12-31140,056USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-5,069,030USD366
2009-05-01 to 2012-12-31-9,699,073USD1341
2011-01-01 to 2011-12-31-3,429,190USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-311,989,495USD
At 2011-12-312,945,429USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-3112,040USD366
2009-05-01 to 2012-12-3139,171USD1341
2011-01-01 to 2011-12-3117,992USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-311,650,598USD
At 2011-12-311,512,173USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-3168,217USD
At 2011-12-3164,766USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-12-314,640,224USD
At 2011-12-3140,841USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-31141,665USD
At 2011-12-311,224USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,485,243USD366
2009-05-01 to 2012-12-3110,019,598USD1341
2011-01-01 to 2011-12-313,333,500USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31416,213USD366
2009-05-01 to 2012-12-31320,523USD1341
2011-01-01 to 2011-12-31-95,690USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-3135,745USD366
2009-05-01 to 2012-12-3140,909USD1341
2011-01-01 to 2011-12-315,164USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3112,919,367shares
At 2011-12-3111,256,867shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3114,894,522USD
At 2011-12-316,200,520USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3131,080USD
At 2011-12-315,998USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-314,676,670USD
At 2011-12-3145,998USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-311,582,381USD
At 2011-12-31442,329USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,018,422USD366
2009-05-01 to 2012-12-319,379,722USD1341
2011-01-01 to 2011-12-313,172,649USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-3125,082USD366
2011-01-01 to 2011-12-313,920USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31130,552USD366
2009-05-01 to 2012-12-31146,175USD1341
2011-01-01 to 2011-12-3115,623USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2009-05-01 to 2012-12-31250USD1341
2011-01-01 to 2011-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-140,441USD366
2009-05-01 to 2012-12-31-141,665USD1341
2011-01-01 to 2011-12-31-1,224USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-29,884USD366
2009-05-01 to 2012-12-31-121,910USD1341
2011-01-01 to 2011-12-31-92,026USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,451USD366
2009-05-01 to 2012-12-3168,217USD1341
2011-01-01 to 2011-12-3164,765USD365

Inspect the source

Entity
ATOSSA THERAPEUTICS, INC. / CIK 0001488039
Captured
2026-09-20T09:09:43.864Z
SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))